AU5294999A - Defensins against ocular infection - Google Patents

Defensins against ocular infection

Info

Publication number
AU5294999A
AU5294999A AU52949/99A AU5294999A AU5294999A AU 5294999 A AU5294999 A AU 5294999A AU 52949/99 A AU52949/99 A AU 52949/99A AU 5294999 A AU5294999 A AU 5294999A AU 5294999 A AU5294999 A AU 5294999A
Authority
AU
Australia
Prior art keywords
ocular infection
against ocular
defensins against
defensins
infection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU52949/99A
Inventor
Harminder Singh Dua
Richard John Haynes
Patrick Jason Tighe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Nottingham
Original Assignee
University of Nottingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Nottingham filed Critical University of Nottingham
Publication of AU5294999A publication Critical patent/AU5294999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU52949/99A 1998-08-08 1999-08-06 Defensins against ocular infection Abandoned AU5294999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9817224 1998-08-08
GBGB9817224.0A GB9817224D0 (en) 1998-08-08 1998-08-08 Ocular surface infection
PCT/GB1999/002591 WO2000007612A1 (en) 1998-08-08 1999-08-06 Defensins against ocular infection

Publications (1)

Publication Number Publication Date
AU5294999A true AU5294999A (en) 2000-02-28

Family

ID=10836884

Family Applications (1)

Application Number Title Priority Date Filing Date
AU52949/99A Abandoned AU5294999A (en) 1998-08-08 1999-08-06 Defensins against ocular infection

Country Status (3)

Country Link
AU (1) AU5294999A (en)
GB (1) GB9817224D0 (en)
WO (1) WO2000007612A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6576755B1 (en) 1997-09-10 2003-06-10 Zymogenetics, Inc. Beta-defensins
US9143477B2 (en) 2000-10-25 2015-09-22 Syniverse Icx Corporation Address recognition database
US6872705B2 (en) * 2001-07-13 2005-03-29 Allergan, Inc. Use of antimicrobial peptides as preservatives in ophthalmic preparations, including solutions, emulsions, and suspensions
JP7555938B2 (en) 2019-01-30 2024-09-25 モンテリノ・セラピューティクス・インコーポレイテッド Bifunctional compounds and methods for targeted ubiquitination of the androgen receptor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242902A (en) * 1989-09-06 1993-09-07 The Regents Of The University Of California Defensin peptide compositions and methods for their use
WO1991016066A1 (en) * 1990-04-23 1991-10-31 Magainin Sciences Inc. Composition and treatment with biologically active peptides and toxic cations
DE4427531A1 (en) * 1994-08-04 1996-02-08 Forssmann Wolf Georg Human beta-defensin 1 isolated from haemofiltrate

Also Published As

Publication number Publication date
GB9817224D0 (en) 1998-10-07
WO2000007612A1 (en) 2000-02-17

Similar Documents

Publication Publication Date Title
AU5166900A (en) Ophthalmic solutions incorporating an antimicrobial polypeptide
AU4344600A (en) Antimicrobial
AU1337800A (en) Electro-optic binocular indirect ophthalmoscope
AU1820099A (en) Medical devices with improved properties
AU5727200A (en) Super vision
AU3276499A (en) Bactericides
AU4167699A (en) Antimicrobial agents
AU1731101A (en) Ophthalmic compositions
AU3979200A (en) Antimicrobial agents
AU5970699A (en) Use
AU1412400A (en) Hydrophilic member
AU1772399A (en) Well treatment
AU7961500A (en) Condom
AU4309700A (en) Spectacles
AU3328600A (en) Ocular tension-lowering agents
AU3307399A (en) Novel antibacterial agents
AU6892900A (en) Antibacterial amidinomethyl- and guanidinomethyl-oxazolidinones
AU5294999A (en) Defensins against ocular infection
AU2227999A (en) Human ependymin
AU5630800A (en) Antimicrobial agents
AU5056499A (en) Ophthalmic device
AU3168899A (en) Antibacterial agents
AU4847999A (en) Antioxidant intraocular lens
AU3698199A (en) Radioimmuno-pharmacon for treating the hiv-1 infection
AU9690798A (en) Goggle

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase